ARROWSTREET CAPITAL, LIMITED PARTNERSHIP HHS — HARTE-HANKS INC

Ownership history in ARROWSTREET CAPITAL, LIMITED PARTNERSHIP  ·  19 quarters on record

AI Ownership Summary

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP reported HARTE-HANKS INC (HHS) in 19 quarterly 13F filings from 2024 Q3 through 2026 Q2. The latest visible filing shows HHS at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this HHS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's position in HARTE-HANKS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

HHS was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

HHS stock page ARROWSTREET CAPITAL, LIMITED PARTNERSHIP fund profile ARROWSTREET CAPITAL, LIMITED PARTNERSHIP full holdings
How ARROWSTREET CAPITAL, LIMITED PARTNERSHIP held HHS — position size vs. price
% of Fund (quarterly)    HHS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED — — — 17,204 — 0% 0.00% $37K 2026-08-13 $2.81
2026 Q1 UNCHANGED — — — 17,204 — 0% 0.00% $39K 2026-05-14 $2.81
2025 Q4 UNCHANGED — — — 17,204 — 0% 0.00% $52K 2026-02-13 $2.81
2025 Q3 UNCHANGED — — — 17,204 — 0% 0.00% $64K 2025-11-14 (Est.) $2.98
2025 Q2 UNCHANGED — — — 17,204 — 0% 0.00% $68K 2025-08-14 (Est.) $3.56
2025 Q1 UNCHANGED — — — 17,204 — 0% 0.00% $83K 2025-05-14 $4.60
2024 Q4 UNCHANGED — — — 17,204 — 0% 0.00% $89K 2025-02-12 $5.43
2024 Q3 REDUCED 94.7% -29.8% ✅ 17,204 -308,797 -94.7% 0.00% $128K 2024-11-14 $7.05
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding HHS

As of 2026 Q2 — sorted by position size

WESTERLY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.25% RAFFLES ASSOCIATES LP 3Y 7Y 0.17% Krilogy Financial LLC 3Y 7Y 0.01% BLAIR WILLIAM & CO/IL 3Y 7Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% LSV ASSET MANAGEMENT 3Y 7Y 0.0% Triumph Capital Management 3Y 0.0%

FAQ About ARROWSTREET CAPITAL, LIMITED PARTNERSHIP and HHS

These are the practical questions this page is built to answer before you even open the full history table.

How long has ARROWSTREET CAPITAL, LIMITED PARTNERSHIP reported owning HHS?

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP reported HHS across 8 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported HHS position in ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio?

The largest reported portfolio weight for HHS was 0.00% in 2024 Q3.

What is the latest reported HHS position on this page?

The most recent filing on this page is 2026 Q2, when ARROWSTREET CAPITAL, LIMITED PARTNERSHIP reported 17,204 shares, equal to 0.00% of portfolio, with an estimated market value of $37K.

What does the chart on this HHS ownership page compare?

The chart compares ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's quarterly HHS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did ARROWSTREET CAPITAL, LIMITED PARTNERSHIP time their HHS position?

Based on 13F filing dates vs. subsequent HHS price moves, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP correctly timed 4 out of 10 reported position changes (40%). The annualised alpha on HHS relative to SPY over the holding period was -20.0%.

← Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Holdings